New Drug Halves Death Rate in Those With Severe COVID, Maker Claims
TUESDAY, April 12, 2022 (HealthDay News) — An experimental medication for critically ill COVID-19 patients appears to work so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. The medication, sabizabulin, halved the death rate in COVID-19 patientsContinue Reading